Skip to content
Search AI Powered

Latest Stories

Veterans Denied: Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing

Republicans Strike Down All Marijuana And Psychedelics Amendments From NDAA

Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing
Government's Indifference to Cannabis and Psychedelics Continues to Hinder Healing

As the National Defense Authorization Act (NDAA) takes center stage in shaping the future of the United States Department of Defense, Congress missed a crucial opportunity to prioritize the well-being of our nation's veterans. 

Amendments that would have expanded access to cannabis and psychedelics for medical purposes were recently rejected in a Rules Committee vote, leaving veterans stranded in their ongoing battle against post-traumatic stress disorder (PTSD) and other ailments.


One such amendment, sponsored by Rep. Dan Crenshaw, sought to create a DOD grant program funding research on the therapeutic benefits of psilocybin and MDMA for treating PTSD and traumatic brain injury (TBI). 

Surprisingly, this proposal garnered support from both Democrats and Republicans, only to be dismissed due to stricter oversight requirements. The decision highlights the government's enduring failure to recognize the urgent need for innovative solutions in veterans' healthcare.

Additionally, a cannabis-related amendment, put forth by House Veterans Affairs Chair Mark Takano, proposed establishing a medical cannabis pilot program for veterans in the VA health care system. This initiative aimed to grant access to medical cannabis for veterans diagnosed with PTSD, depression, or anxiety. 

Nevertheless, it was also blocked from inclusion in the NDAA, denying veterans a potentially safer and more effective alternative to traditional treatments.

These decisions are a blow to the countless veterans who have found relief and improved quality of life through the use of cannabis and psychedelics. Multiple studies, including a recent survey of over 500 military veterans, demonstrate that medicinal cannabis can lead to a greater quality of life and a reduced reliance on prescription and over-the-counter medications. It is disheartening to see the government overlook such compelling evidence in favor of over-politicized and antiquated stances on cannabis and psychedelics.

The consequences of these omissions are far-reaching. Veterans are left to grapple with debilitating conditions, struggling to access effective treatment options. For those who have exhausted traditional remedies, cannabis and psychedelics offer new hope, paving the way for innovative approaches in managing mental health issues.

Moreover, veterans are being denied access to potential breakthroughs in mental health treatments. Rep. Ken Buck's proposal, which recommended recognizing MDMA as a viable treatment for PTSD, aimed to push the Department of Veterans Affairs (VA) to develop a plan for its approval. This decision represents a missed opportunity to explore promising avenues of healing for our brave servicemen and women.

Congress must acknowledge the growing support for marijuana reform and the positive impact it has on veterans. Medicinal cannabis can serve as a crucial harm-reduction tool, reducing the need for numerous pharmaceutical medications and other substances that often come with dangerous side effects. Veterans deserve access to alternative treatments that have shown real promise in alleviating their suffering.

It is long-past time for the government to prioritize the well-being of our veterans over outdated misconceptions about cannabis and psychedelics. By supporting these and similar amendments, Congress can take a significant step towards honoring the service and sacrifice of our veterans. Failure to do so will perpetuate the government's neglect of the very heroes it should be standing beside. 

As the debates on marijuana reform and psychedelics continue, we implore Congress to seize the opportunity to enact meaningful change for veterans. Let us not overlook the overwhelmingly positive results veterans have experienced firsthand with both cannabis and psychedelics. By including these amendments in the NDAA, our government can finally demonstrate its unwavering commitment to those who have risked their lives to protect our nation's freedom. 

Additional information on Marijuana and Veterans is available from the NORML Fact Sheet, Marijuana and Veterans Issues.’

More For You

OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
OCM Alleges 'Rent-a-License' Scheme, Seeks License Revocation
Photo by Jon Tyson on Unsplash

NY Revokes License in Rent-a-License Scam

At-a-Glance

  • What’s new: NY’s Office of Cannabis Management (OCM) issued a Notice of Pleading (NOP) charging Omnium Health (d/b/a Omnium Canna) with facilitating unlicensed production under its license and ordered a statewide retail recall tied to products made by unlicensed processors.
  • Why it matters: Regulators call it “reverse licensing” - unlicensed operators allegedly producing/packaging cannabis under a licensee’s umbrella, which undermines market integrity and fairness.
  • Penalties sought: License revocation (processor + distributor), debarment from future licensure, civil penalties tied to projected revenue, and destruction of unlawfully made products.
  • Timeline: Investigation began February 2025; OCM announcement issued October 20, 2025; coverage followed October 22, 2025.

What Exactly Is OCM Alleging?

OCM says Omnium let unlicensed businesses use its facilities and resources, and charged them rent, creating a “rent-a-license” (aka “reverse licensing”) arrangement. Investigators cite contracts, audits, and witness testimony supporting the claim.

The NOP also points to seized materials, including unlabeled THCA isolate (no batch IDs or traceability) and packaging labeled “Omnium d/b/a MFused,” which investigators say reflected space and license rental.

Keep ReadingShow less
gif of actor Kevin James from King of Queens; asking "How Much Does That Cost?"
Why Is Some Weed More Expensive Than Others? Understanding Cannabis Pricing
Giphy

Unraveling Cannabis Pricing: Factors Behind the Cost of Weed


Step inside a cannabis dispensary for the first time and the experience can be overwhelming. The meticulously labeled glass jars showcase dozens of strains with names like "Wedding Cake" and "Blue Dream," while refrigerated cases display concentrates, edibles, and tinctures at wildly different price points. Unlike the days when consumers were limited to whatever their neighborhood dealer offered, today's legal market presents a dazzling array of options that might leave newcomers with both wonder and sticker shock.

Keep ReadingShow less
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Cannabis and Aging: A Groundbreaking Study Challenges Long-Held Beliefs - The Bluntness
Giphy

Aging & Cannabis: New Findings

For decades, cannabis has been widely regarded as a substance with potential cognitive risks, particularly when used over long periods. Governments across the globe have classified it as a controlled substance, citing concerns about the effects of marijuana use, including memory loss, diminished executive function, and long-term neurological impact. But new research is challenging this long-standing assumption, suggesting that cannabis use may not be linked to age-related cognitive decline—and might even be associated with better cognitive preservation over time.

A recent study published in PubMed (NIH, 2024) followed over 5,000 men for more than four decades to analyze the long-term cognitive effects of cannabis use. The results? Men with a history of cannabis use experienced less cognitive decline from early adulthood to late midlife compared to those who never used cannabis.

Keep ReadingShow less
Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Hall of Flowers NYC Debut: Cali Vibes Minus the Pulse of NY Cannabis

Photo courtesy of Hall of Flowers

Hall of Flowers NYC 2025: Cali Vibes Minus the Pulse of NY Cannabis

Upon entering through the doors at Pier 36 it was refreshing to see row after row of identical booths, neat as a spreadsheet, designed to let the product speak for itself. Buyers drifted through the aisles with line sheets instead of selfie sticks, the volume dialed way down compared to last month's Revelry event at the same location. And, maybe that was the point. Hall of Flowers’ first New York edition was designed for commerce, not commotion: a buyers-only opening day, tight credentialing, a controlled environment and pace that favored real conversations over spectacle.

The uniformity of Hall of Flowers' format erased the booth-flex arms race; most of the brands stood shoulder-to-shoulder on product, pricing, and execution. “Much easier to have conversations here than at Revelry,” several attendees told us. Others called it “weak” or “quiet” by comparison. One marketing exec involved in the event went all in saying, “Revelry is a flea market compared to Hall of Flowers.” What he meant by that is: Hall of Flowers is a curated, high-end trade event, whereas Revelry functions more as a community marketplace. I could see his point.

Keep ReadingShow less
Lights, Camera, Cannabis: The New Theater Experience
Cigar smoking in a bar....
Giphy

NY Movie Theaters: High on Cannabis Lounges

In the dimly lit ambiance of New York City's historic movie theaters, the scent of buttered popcorn has long been the olfactory hallmark. However, as cannabis legalization sweeps across the state, a provocative question emerges: Could the future of cinema include the aroma of cannabis alongside the traditional concessions?

The Current Landscape of Cannabis Consumption Lounges

New York State’s Clean Indoor Air Act (CIAA) casts a long shadow over this budding idea. Enacted to safeguard public health, the CIAA prohibits smoking and vaping in most indoor workplaces, encompassing bars, restaurants, and, notably, movie theaters. The act defines smoking expansively, including the burning of tobacco, cannabis, or cannabinoid-hemp products. Violations can result in fines up to $2,000 for each infraction, underscoring the state’s commitment to maintaining smoke-free public spaces.

Keep ReadingShow less